<DOC>
	<DOCNO>NCT02792920</DOCNO>
	<brief_summary>To compare early late clinical outcome everolimus-eluting cobalt-chromium stent patient ST-elevation acute myocardial infarction , well identify characteristic efficacy CoCr-EES . Also , OCT sub-analysis conduct</brief_summary>
	<brief_title>Multicenter Registry Very Early Late Clinical Outcomes Everolimus-eluting Cobalt-Chromium Stent In Patients With ST Elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>1 . Patients STEMI able undergo CoCrEES implantation . 2 . Patients history PCI target vessel 3 . Patients 20 old time inform consent 4 . Patients provide write informed consent himself/herself 5 . Patients judge treat physician able undergo PCI CoCrEES 6 . Patients thrombus aspiration prior CoCrEES implantation recommend 7 . Patients meet follow vascular inclusion criterion i.Patients target lesion native coronary artery ii.Patients visual maximum vessel diameter target stent site target lesion 8 . Patients obtain finally revascularization TIMI 3 visual observation target vessel 9 . Patients able treat CoCrEES diameter 2.5mm 3.5mm less length 8mm 28mm less . 1 . Patients participate ongoing registry clinical study ( except postmarketing surveillance CoCrEES ) , receive treatment may impact endpoint study . 2 . Patients present cardiogenic shock 3 . Patients 12month 36month CAG clinical follow consider difficult ( patient 's residence also take account ) 4 . Patients responsible lesion leave main trunk 5 . Patients renal insufficiency chronic renal failure serum creatinine level 2.0mg/dL high visit 6 . Patients hemodialysis 7 . Patients known history adverse drug reaction aspirin , clopidogrel prasugrel ( This may apply safety ticlopidine confirm alternative drug . ) 8 . Patients age 20 9 . Women positive pregnancy test wish become pregnant study duration 10 . Patients newly develop AMI attributable prior stented site 11 . Patients known history allergy drug , polymer , metal , material use CoCrEES 12 . Patients diagnose hepatic insufficiency 13 . Patients target lesion saphenous vein graft 14 . Patients active malignant tumor</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>